PCN89 COST-EFFECTIVENESS OF NIVOLUMAB AS ADJUVANT TREATMENT OF MELANOMA IN ADULTS WITH INVOLVEMENT OF LYMPH NODES OR METASTATIC DISEASE WHO HAVE UNDERGONE COMPLETE RESECTION IN BELGIUM
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.286
https://www.valueinhealthjournal.com/article/S1098-3015(19)32664-6/fulltext
Title :
PCN89 COST-EFFECTIVENESS OF NIVOLUMAB AS ADJUVANT TREATMENT OF MELANOMA IN ADULTS WITH INVOLVEMENT OF LYMPH NODES OR METASTATIC DISEASE WHO HAVE UNDERGONE COMPLETE RESECTION IN BELGIUM
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32664-6&doi=10.1016/j.jval.2019.09.286
First page :
Section Title :
Open access? :
No
Section Order :
10229